70
55
Growth Score 70 in past quarter
-21 pts
Heat Score 55 in past quarter
-15 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
419036
Polpharma is a drug manufacturing firm that produces generic drugs and high-quality pharmaceuticals for medical industry.
- Markus Sieger: CEOPast Role: Medicines for Europe, Vice President
Agnieszka Ceszlak: Head of Analytical Development and Validation & Stability Departments and Head of Analytical SectionPast Role: Polpharma, Head of Analytical Development Department
About the Company
Polpharma is a leading producer of generic drugs in Central and Eastern Europe, Russia, and Kazakhstan. they create many opportunities for our employees to realize their full professional potential. They offer excellent prospects for career development in an international environment. The progress and implementation of standards and processes for
the entire Polpharma Group starts in Poland.